Bioventix (LON:BVXP) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Bioventix PLC (LON:BVXPGet Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 3,813.93 ($47.61) and traded as low as GBX 3,100 ($38.70). Bioventix shares last traded at GBX 3,145.71 ($39.27), with a volume of 12,029 shares changing hands.

Bioventix Stock Performance

The stock has a market capitalization of £164.21 million, a price-to-earnings ratio of 1,929.88 and a beta of 0.35. The company’s 50 day moving average is GBX 3,420.35 and its 200 day moving average is GBX 3,810.62.

Bioventix (LON:BVXPGet Free Report) last released its earnings results on Monday, October 28th. The biotechnology company reported GBX 155.12 ($1.94) EPS for the quarter. Bioventix had a net margin of 63.73% and a return on equity of 79.14%. On average, equities research analysts anticipate that Bioventix PLC will post 166.3066955 earnings per share for the current fiscal year.

Bioventix Increases Dividend

The firm also recently declared a dividend, which was paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th were issued a GBX 87 ($1.09) dividend. This represents a yield of 2.4%. The ex-dividend date was Thursday, November 7th. This is a positive change from Bioventix’s previous dividend of $68.00. Bioventix’s payout ratio is 9,693.25%.

Insider Buying and Selling at Bioventix

In other news, insider Bruce Hiscock bought 24 shares of the stock in a transaction dated Friday, November 22nd. The shares were acquired at an average price of GBX 3,822 ($47.71) per share, with a total value of £917.28 ($1,145.03). Insiders have acquired 385 shares of company stock valued at $1,107,381 in the last 90 days. 8.02% of the stock is currently owned by company insiders.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

Featured Articles

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.